Midatech Pharma plc
Index- P/E- EPS (ttm)-0.45 Insider Own- Shs Outstand19.56M Perf Week4.91%
Market Cap12.19M Forward P/E- EPS next Y- Insider Trans- Shs Float12.55M Perf Month3.47%
Income-6.70M PEG- EPS next Q- Inst Own5.30% Short Float0.43% Perf Quarter41.91%
Sales0.70M P/S17.41 EPS this Y86.90% Inst Trans4.33% Short Ratio0.26 Perf Half Y-26.96%
Book/sh0.65 P/B1.15 EPS next Y- ROA-50.80% Target Price- Perf Year-59.00%
Cash/sh0.75 P/C0.99 EPS next 5Y- ROE-85.80% 52W Range0.38 - 1.92 Perf YTD-29.05%
Dividend- P/FCF- EPS past 5Y- ROI-56.20% 52W High-61.20% Beta2.32
Dividend %- Quick Ratio6.40 Sales past 5Y- Gross Margin- 52W Low96.05% ATR0.07
Employees20 Current Ratio6.40 Sales Q/Q0.00% Oper. Margin- RSI (14)57.70 Volatility8.65% 9.74%
OptionableNo Debt/Eq0.08 EPS Q/Q89.20% Profit Margin- Rel Volume0.20 Prev Close0.77
ShortableYes LT Debt/Eq0.06 Earnings- Payout- Avg Volume209.39K Price0.75
Recom- SMA208.92% SMA5017.44% SMA200-21.40% Volume42,459 Change-3.25%
Jun-21-22 02:00AM  
Jun-20-22 01:45PM  
Jun-10-22 02:00AM  
Jun-01-22 09:14AM  
May-24-22 06:40AM  
Apr-26-22 02:00AM  
Apr-14-22 08:10AM  
Mar-09-22 02:00AM  
Mar-08-22 05:00AM  
Jan-17-22 02:00AM  
Dec-13-21 05:20AM  
Nov-13-21 03:38AM  
Sep-06-21 02:00AM  
Jul-12-21 09:50AM  
Jun-29-21 09:01AM  
Jun-17-21 08:35AM  
Jun-09-21 02:00AM  
May-21-21 11:15AM  
May-17-21 04:35AM  
Apr-30-21 10:15AM  
Mar-25-21 07:58AM  
Feb-17-21 02:00AM  
Dec-11-20 12:15PM  
Nov-24-20 02:00AM  
Oct-19-20 02:00AM  
Sep-10-20 02:00AM  
Sep-07-20 06:20AM  
Aug-28-20 02:00AM  
Aug-19-20 02:00AM  
Aug-14-20 02:00AM  
Jul-23-20 02:00AM  
Jul-03-20 02:00AM  
Jun-30-20 09:40AM  
Jun-24-20 12:18PM  
Jun-17-20 02:00AM  
Jun-16-20 02:00AM  
Jun-09-20 11:35AM  
May-22-20 06:00AM  
May-21-20 02:01AM  
May-19-20 07:15AM  
May-18-20 10:20AM  
May-12-20 12:55PM  
May-01-20 07:00AM  
Apr-22-20 11:30AM  
Apr-20-20 01:10PM  
Mar-31-20 02:00AM  
Mar-02-20 11:25AM  
Feb-12-20 09:50AM  
Jan-08-20 08:12AM  
Dec-17-19 07:56AM  
Dec-16-19 06:20PM  
Dec-05-19 09:10AM  
Nov-14-19 05:54AM  
Oct-28-19 03:05AM  
Jul-19-19 03:24PM  
May-09-19 10:30AM  
Feb-27-19 10:00AM  
Jan-29-19 06:42AM  
Dec-11-18 03:17AM  
Oct-10-18 04:28AM  
Oct-03-18 11:00AM  
Sep-27-18 07:00AM  
Sep-18-18 06:36AM  
Sep-07-18 10:30AM  
Aug-31-18 07:00AM  
Jul-25-18 07:00AM  
Jul-23-18 09:23AM  
Jun-08-18 02:00AM  
May-29-18 02:51PM  
May-25-18 07:00AM  
May-03-18 08:20AM  
Apr-27-18 09:45AM  
Mar-23-18 03:32AM  
Mar-15-18 08:01AM  
Mar-07-18 10:15AM  
Feb-28-18 07:00AM  
Feb-14-18 07:00AM  
Jan-16-18 07:01AM  
Jan-12-18 12:00PM  
Nov-27-17 03:00PM  
Oct-27-17 01:59PM  
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.